Antiaging Quantum Living Inc.
AAQL
$0.60
-$0.10-13.74%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 26.45% | 147.28% | 194.63% | 335.36% | 10,806.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.45% | 147.28% | 194.63% | 335.36% | 10,806.67% |
| Cost of Revenue | -14.69% | 3,074.24% | 3,129.22% | 44,500.00% | 48,587.50% |
| Gross Profit | 63.85% | 33.65% | 71.22% | 122.42% | 6,295.52% |
| SG&A Expenses | 26.19% | -4.31% | 5.08% | 46.10% | 190.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.29% | 39.17% | 46.85% | 101.27% | 282.35% |
| Operating Income | -5.75% | 26.52% | 26.34% | -19.59% | -91.26% |
| Income Before Tax | -13.96% | 21.47% | 36.74% | -6.15% | -74.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.28% | 19.41% | 34.61% | -7.15% | -74.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.28% | 19.41% | 34.61% | -7.15% | -74.43% |
| EBIT | -5.75% | 26.52% | 26.34% | -19.59% | -91.26% |
| EBITDA | -8.47% | 36.46% | 39.93% | 2.67% | -59.06% |
| EPS Basic | -7.92% | 20.97% | 34.38% | -7.58% | -75.18% |
| Normalized Basic EPS | -6.67% | 23.21% | 36.65% | -5.60% | -74.42% |
| EPS Diluted | -7.92% | 20.97% | 34.38% | -7.58% | -75.18% |
| Normalized Diluted EPS | -6.67% | 23.21% | 36.65% | -5.60% | -74.42% |
| Average Basic Shares Outstanding | 5.00% | 1.47% | 0.04% | -0.04% | -0.04% |
| Average Diluted Shares Outstanding | 5.00% | 1.47% | 0.04% | -0.04% | -0.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |